Business description
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.
Management board & Supervisory board
| CEO |
| Robert B. Ford |
| Management board |
| Robert E. Funck, Jr., Alejandro Wellisch, Andrea F. Wainer, Andrew H. Lane, Christopher J. Calamari, Daniel Salvadori, Dr. John M. Capek, Greg Ahlberg, Hubert L. Allen, J. Scott House, Jared L. Watkin, John F. Ginascol, Joseph Manning, Julie Tyler, Lisa D. Earnhardt, Louis H. Morrone, Mary K. Moreland, Michael Dale, Michael J. Pederson, Randel Woodgrift, Sammy G. Karam |
| Supervisory board |
| Robert B. Ford, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, Glenn F. Tilton, John G. Stratton, Michael F. Roman, Michelle A. Kumbier, Nancy McKinstry, Patricia P. Gonzalez, Robert J. Alpern, Roxanne S. Austin, William A. Osborn |
Company data
| Name: |
Abbott Laboratories |
| Address: |
100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA |
| Phone: |
+1-224-667-6100 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.abbott.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
87.10% |
| IPO date: |
- |
Investor relations
| Name: |
Scott Leinenweber |
| IR phone: |
+1-224-667-8945 |
| IR Fax: |
- |
| IR e-mail: |
-
|